Figure 2.
ONX-0914 treated cells upregulate β5c. (A) RPMI-8226 cells were treated as shown. At times indicated, either total β5 (β5i + β5c) activity was measured with Suc-LLVY-amc (n = 2) (B) or individual subunits were measured with ABPs (n = 2) (C).